Are treatment sequences, adverse events, long-term disease progression adequately considered in cost-effectiveness analyses of rheumatoid arthritis ?- A critical economic litterature review
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1104
https://www.valueinhealthjournal.com/article/S1098-3015(16)32470-6/fulltext
Title :
Are treatment sequences, adverse events, long-term disease progression adequately considered in cost-effectiveness analyses of rheumatoid arthritis ?- A critical economic litterature review
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32470-6&doi=10.1016/j.jval.2016.09.1104
First page :
A536
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1033